The New Coronavirus Vaccine may be Available in the United States!

The United States' new coronavirus vaccine is undergoing the third phase of clinical trials. If the vaccine trial data is good, the vaccine can be given to medical staff and other high-risk groups before the third phase is completed.

The U.S. Centers for Disease Control and Prevention (CDC) has formulated technical specifications for the transportation, storage and management of vaccines developed by Pfizer and Modena.

On August 27th, the CDC sent three documents to all public health officials in 50 states and 5 large cities, asking them to prepare vaccine distribution locations by November 1. There is a passage in it : 'CDC urgently requests your assistance in expediting the approval of these facilities. If necessary, please consider giving up the permit requirements so that these facilities will be fully operational before November 1, 2020.' This shows the importance of widespread vaccination of the people to CDC.

Faced with the CDC’s behavior, Redfield said, 'License exemption' will not compromise the safety or integrity of the distributed products. You assist in expediting the necessary permits and permits required to operate the vaccination site. The success of the work is essential to alleviate the threat posed by the new coronavirus.' One of te three documents include vaccination guidelines, two doses of vaccine per person, several weeks apart was instructed. The first batch of vaccinators are hospitals, clinics and other nursing facilities. The staff, as well as national security employees and first responders. In addition, the guide prioritizes people 65 years of age and older, as well as Native Americans and prisoners from 'racial and minority populations', or imprisoned. Now this act also completely dispels people's previous speculation that the 'rich' should be vaccinated first.

The vaccine jointly developed by Pfizer and German biotechnology company is the fastest among many vaccine manufacturers. Pfizer is able to ensure that about 2 million doses of vaccine will be prepared by the end of October, which can be injected by 1 million people, while Moderna will be able to prepare about 1 million doses of vaccine by the end of the year.

In order to allow every American to be vaccinated, the United States has taken the first batch of vaccines from major global pharmaceutical companies. At the same time, regarding the cost of vaccination, the official stated that if there is insurance, the insurance company will bear it. If there is no insurance, It is borne by the government, and individuals do not need to spend a penny.

At the end of July, the Trump administration ordered 100 million doses of vaccines from Pfizer and German biotech companies, valued at US$1.95 billion.

Subsequently, the Trump administration ordered a vaccine developed by Oxford University from the British-based AstraZeneca Pharmaceutical Company at a price of US$1.2 billion. In addition, it also spent $939 million to order vaccines developed by Moderna and Johnson & Johnson.

A few days later, the Trump administration spent another $2.1 billion to test and produce 100 million doses of experimental coronavirus vaccine.

Trump spent billions of dollars to purchase vaccines. Once emergency authorization is obtained from the FDA, the vaccines in the United States can be marketed.